Biotech Rally Fizzles As Global Healthcare Issues Weigh…Update-1

The strong biotech rally fizzled early this week as longer term healthcare issues weighed on investors. High expectations from breakthrough products were tempered by the lingering long term concerns of drug pricing and healthcare reform.
Data & News supplied by
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.